These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33095511)

  • 1. Characterization of New DNA Aptamers for Anti-HIV-1 Reverse Transcriptase.
    Ratanabunyong S; Aeksiri N; Yanaka S; Yagi-Utsumi M; Kato K; Choowongkomon K; Hannongbua S
    Chembiochem; 2021 Mar; 22(5):915-923. PubMed ID: 33095511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical Characterization of Novel DNA Aptamers against K103N/Y181C Double Mutant HIV-1 Reverse Transcriptase.
    Ratanabunyong S; Seetaha S; Hannongbua S; Yanaka S; Yagi-Utsumi M; Kato K; Paemanee A; Choowongkomon K
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-protein interactions govern antiviral specificity and encapsidation of broad spectrum anti-HIV reverse transcriptase aptamers.
    Lange MJ; Nguyen PDM; Callaway MK; Johnson MC; Burke DH
    Nucleic Acids Res; 2017 Jun; 45(10):6087-6097. PubMed ID: 28334941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs.
    Kissel JD; Held DM; Hardy RW; Burke DH
    AIDS Res Hum Retroviruses; 2007 May; 23(5):699-708. PubMed ID: 17530996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
    Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
    J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers.
    Kissel JD; Held DM; Hardy RW; Burke DH
    Nucleic Acids Res; 2007; 35(15):5039-50. PubMed ID: 17644816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites.
    Losada N; Ruiz FX; Curreli F; Gruber K; Pilch A; Das K; Debnath AK; Arnold E
    J Med Chem; 2021 Nov; 64(22):16530-16540. PubMed ID: 34735153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
    Tabassum T; Azeem SM; Muwonge AN; Frey KM
    Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-fluoro-modified pyrimidines enhance affinity of RNA oligonucleotides to HIV-1 reverse transcriptase.
    Gruenke PR; Alam KK; Singh K; Burke DH
    RNA; 2020 Nov; 26(11):1667-1679. PubMed ID: 32732393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.
    Buckheit RW; White EL; Fliakas-Boltz V; Russell J; Stup TL; Kinjerski TL; Osterling MC; Weigand A; Bader JP
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1827-34. PubMed ID: 10428899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of novel inhibitors of HIV-1 reverse transcriptase with a reporter ribozyme assay.
    Yamazaki S; Famulok M
    Methods Mol Biol; 2009; 535():187-99. PubMed ID: 19377995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers that recognize drug-resistant HIV-1 reverse transcriptase.
    Li N; Wang Y; Pothukuchy A; Syrett A; Husain N; Gopalakrisha S; Kosaraju P; Ellington AD
    Nucleic Acids Res; 2008 Dec; 36(21):6739-51. PubMed ID: 18948292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of 2'-deoxy-2'-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity.
    Alves Ferreira-Bravo I; Cozens C; Holliger P; DeStefano JJ
    Nucleic Acids Res; 2015 Nov; 43(20):9587-99. PubMed ID: 26476448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.
    Urano E; Miyauchi K; Kojima Y; Hamatake M; Ablan SD; Fudo S; Freed EO; Hoshino T; Komano J
    ChemMedChem; 2016 Oct; 11(20):2320-2326. PubMed ID: 27634404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase.
    Sohl CD; Kasiviswanathan R; Kim J; Pradere U; Schinazi RF; Copeland WC; Mitsuya H; Baba M; Anderson KS
    Mol Pharmacol; 2012 Jul; 82(1):125-33. PubMed ID: 22513406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
    La Regina G; Coluccia A; Silvestri R
    Antivir Chem Chemother; 2010 Aug; 20(6):213-37. PubMed ID: 20710063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
    Whitcomb JM; Huang W; Limoli K; Paxinos E; Wrin T; Skowron G; Deeks SG; Bates M; Hellmann NS; Petropoulos CJ
    AIDS; 2002 Oct; 16(15):F41-7. PubMed ID: 12370521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Balzarini J
    Curr Top Med Chem; 2004; 4(9):921-44. PubMed ID: 15134549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.